Citigroup Inc Quidel Ortho Corp Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Quidel Ortho Corp stock. As of the latest transaction made, Citigroup Inc holds 37,530 shares of QDEL stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,530

Previous 8,525 340.23%

Holding current value

$1.65 Million

Previous $283,000 504.24%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$29.96 - $46.4 $868,989 - $1.35 Million	29,005 Added 340.23%	37,530 $1.71 Million
Q2 2024 Aug 12, 2024	SELL	$32.9 - $47.0 $237,998 - $339,998	-7,234 Reduced 45.9%	8,525 $283,000
Q1 2024 May 10, 2024	BUY	$41.76 - $74.73 $340,511 - $609,348	8,154 Added 107.22%	15,759 $755,000
Q4 2023 Feb 09, 2024	BUY	$58.16 - $75.44 $104,513 - $135,565	1,797 Added 30.94%	7,605 $560,000
Q3 2023 Nov 09, 2023	BUY	$70.9 - $88.63 $82,314 - $102,899	1,161 Added 24.98%	5,808 $424,000
Q2 2023 Aug 10, 2023	SELL	$81.09 - $94.16 $165,018 - $191,615	-2,035 Reduced 30.45%	4,647 $385,000
Q1 2023 May 11, 2023	SELL	$82.98 - $91.46 $554,472 - $611,135	-6,682 Reduced 50.0%	6,682 $595,000
Q4 2022 Feb 09, 2023	SELL	$66.93 - $97.5 $761,596 - $1.11 Million	-11,379 Reduced 45.99%	13,364 $1.14 Million
Q3 2022 Nov 10, 2022	BUY	$69.86 - $107.63 $712,152 - $1.1 Million	10,194 Added 70.07%	24,743 $1.77 Million
Q2 2022 Aug 10, 2022	BUY	$89.06 - $117.64 $1.3 Million - $1.71 Million	14,549 New	14,549 $1.41 Million

Others Institutions Holding QDEL

# of Institutions

292

Shares Held

67.7M

Call Options Held

337K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.94B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account